(Q39959226)

English

Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Anil Kumar Podichetty

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Stefan Wagner

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Andreas Faust

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Michael Schäfers

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Otmar Schober

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Klaus Kopka

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Günter Haufe

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Future Medicinal Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

969-989

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Prospects for caspase inhibitors.

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

The biochemistry of apoptosis

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

The role of caspase cleavage of tau in Alzheimer disease neuropathology

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Biomarkers for apoptosis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL.

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Advances in apoptosis research

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

New approaches and therapeutics targeting apoptosis in disease

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Apoptosis genes and autoimmunity.

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Regulation of caspase activation in apoptosis: implications in pathogenesis and treatment of disease

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Apoptosis: target for novel drugs

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Inhibition of human caspases by peptide-based and macromolecular inhibitors

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Apoptosis-detecting radioligands: current state of the art and future perspectives

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Potent and selective nonpeptide inhibitors of caspases 3 and 7.

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Design, synthesis, and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18F]fluoroethylazide

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis.

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

[18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98.

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-phenylbutanoyl-L-prolyl-2(S)-acylpyrrolidines as prolyl oligopeptidase inhibitors.

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Biomimetic modeling of oxidative drug metabolism : Strategies, advantages and limitations

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Synthesis of analogs of 1,3-dihydroxyacetone phosphate and glyceraldehyde 3-phosphate for use in studies of fructose-1,6-diphosphate aldolase

1 reference

https://api.crossref.org/works/10.4155%2FFMC.09.66

21 January 2018

Identifiers

10.4155/FMC.09.66

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

release_3f2tt364gna55cf7pnmbtsxide

1 reference

https://api.fatcat.wiki/v0/release/3f2tt364gna55cf7pnmbtsxide

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39959226&oldid=1881265756"